GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,500 MG PER 150 ML (10 MG/ML) - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 88125486
Serial Number
88125486
Registration Number
6200988
Word Mark
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,500 MG PER 150 ML (10 MG/ML)
Status
700 - Registered
Status Date
2020-11-17
Filing Date
2018-09-20
Registration Number
6200988
Registration Date
2020-11-17
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
261113, 261121, 261709 - Two rectangles. Rectangles that are completely or partially shaded. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2019-02-26
Attorney Name
Craig Kuchii, Esq.
Law Office Assigned Location Code
N40
Employee Name
GANESH, HARINI
Statements
Indication of Colors claimed
The color(s) pink, white and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,500 MG PER 150 ML (10 MG/ML)"
Description of Mark
The mark consists of a pink outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" in black lettering, along with a pink arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in pink, with the words "1,500 mg per 150 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
Goods and Services
medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
Goods and Services
medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-09-26
Primary Code
005
First Use Anywhere Date
2020-07-08
First Use In Commerce Date
2020-07-08
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2018-09-26
Primary Code
010
First Use Anywhere Date
2020-07-08
First Use In Commerce Date
2020-07-08
Current Trademark Owners
Party Name
Sun Pharmaceutical Industries Limited
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Sun Pharmaceutical Industries Limited
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Sun Pharmaceutical Industries Limited
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Sun Pharmaceutical Industries Limited
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Craig Kuchii, Esq.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-09-24NEW APPLICATION ENTERED IN TRAM
2018-09-26NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-09-27NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-11-27ASSIGNED TO EXAMINER
2018-11-29EXAMINERS AMENDMENT -WRITTEN
2018-11-29EXAMINERS AMENDMENT E-MAILED
2018-11-29NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2018-11-29EXAMINER'S AMENDMENT ENTERED
2018-11-29APPROVED FOR PUB - PRINCIPAL REGISTER
2018-12-21ASSIGNED TO LIE
2019-01-08WITHDRAWN FROM PUB - OG REVIEW QUERY
2019-01-14PREVIOUS ALLOWANCE COUNT WITHDRAWN
2019-01-15EXAMINERS AMENDMENT -WRITTEN
2019-01-15EXAMINERS AMENDMENT E-MAILED
2019-01-15NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2019-01-15EXAMINER'S AMENDMENT ENTERED
2019-01-18APPROVED FOR PUB - PRINCIPAL REGISTER
2019-02-06NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-02-26PUBLISHED FOR OPPOSITION
2019-02-26OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-04-23NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-10-23TEAS EXTENSION RECEIVED
2019-10-23EXTENSION 1 FILED
2019-10-23EXTENSION 1 GRANTED
2019-10-25NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-04-22TEAS EXTENSION RECEIVED
2020-04-22EXTENSION 2 FILED
2020-04-22EXTENSION 2 GRANTED
2020-04-24NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-09-29TEAS STATEMENT OF USE RECEIVED
2020-10-13CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-09-29USE AMENDMENT FILED
2020-10-13STATEMENT OF USE PROCESSING COMPLETE
2020-10-15ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2020-10-16NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2020-11-17REGISTERED-PRINCIPAL REGISTER